Bedrosian Camille L

Amylyx Pharmaceuticals, Inc. · Chief Medical Officer

Bedrosian Camille L is listed in public filings as officer: Chief Medical Officer. This Bedrosian Camille L insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Amylyx Pharmaceuticals, Inc. (AMLX), Rhythm Pharmaceuticals, Inc. (RYTM), and Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX). Investors use Bedrosian Camille L's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Amylyx Pharmaceuticals, Inc.AMLX$2.0M144k sharesGrant / ExerciseMar 5, 2026$2.0M144k shares$14.10--
Amylyx Pharmaceuticals, Inc.AMLX--265.3k sharesGrant / ExerciseMar 5, 2026Disclosure amount unavailable96k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Amylyx Pharmaceuticals, Inc.AMLX$2.5M169.3k sharesSellMar 2, 2026$94.2K6.5k shares$14.58--
Amylyx Pharmaceuticals, Inc.AMLX$2.5M175.8k sharesSellDec 1, 2025$94.4K6.6k shares$14.35--
Amylyx Pharmaceuticals, Inc.AMLX$2.7M182.3k sharesSellSep 30, 2025$175.5K12k shares$14.58--
Rhythm Pharmaceuticals, Inc.RYTM$448k7k sharesGrant / ExerciseJun 24, 2025$448.0K7k shares$63.66--
Rhythm Pharmaceuticals, Inc.RYTM--4.7k sharesGrant / ExerciseJun 24, 2025Disclosure amount unavailable4.7k shares----
Rhythm Pharmaceuticals, Inc.RYTM--4k sharesGrant / ExerciseJun 18, 2025Disclosure amount unavailable4k shares----
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX$335k10.4k sharesGrant / ExerciseJun 11, 2025$334.6K10.4k shares$32.33--
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)CRNX--16.3k sharesGrant / ExerciseJun 11, 2025Disclosure amount unavailable6.9k shares----
Amylyx Pharmaceuticals, Inc.AMLX$674k194.4k sharesSellMar 31, 2025$43.1K12.4k shares$3.47--
Amylyx Pharmaceuticals, Inc.AMLX$370k102.6k sharesGrant / ExerciseMar 6, 2025$370.5K102.6k shares$3.61--
Amylyx Pharmaceuticals, Inc.AMLX--206.8k sharesGrant / ExerciseMar 6, 2025Disclosure amount unavailable68.4k shares----
Amylyx Pharmaceuticals, Inc.AMLX$766k138.4k sharesSellDec 2, 2024$30.0K5.4k shares$5.54--
Amylyx Pharmaceuticals, Inc.AMLX$459k143.8k sharesSellSep 30, 2024$36.6K11.4k shares$3.20--